Not only Johnson & Johnson, but other pharmaceutical companies are also trying to get in touch with Fu Liang

Some made phone calls, some sent emails, and some even sent representatives in person.

Their Zhang Jian is the same, and they want to persuade Fu Liang not to lower the price of other medicines.

ask for flowers

Almost all of the world's top pharmaceutical companies such as Roche, Bayer, and GlaxoSmithKline produce antihypertensive drugs that require long-term use

These drugs are also one of the main sources of income for many pharmaceutical companies.

All of a sudden, they were fooled by Fu Liang’s price cut, so they had to passively cut prices and rush to promote them, otherwise there would be a backlog of products.

When Fu Liang's new drug is launched next year, the impact on their side will definitely be greater, and it is possible that the sales of many drugs will shrink by [-]%!

The representatives of these pharmaceutical companies discussed, they need to do two things, so that Fu Liang can see their attitude and will not continue to suppress them

The first thing is to continue to work together to suppress Pfizer.

For example, the previous argument about the acquisition of Sun Pharmaceutical by Pai Rui is not over yet. It does not mean that Pfizer sold the equity of Sun Pharmaceutical again.

The second thing is that they want to tell people all over the world that the drugs developed by Fu Liang are already very cheap on the market. This is a conscientious pharmaceutical company and cannot be

Some jealous peers ruined!

Otherwise, if it goes on like this, Fu Liang will still be able to increase the price. What will they do?

Have you watched your company's profit margin change from [-]% to [-]%?

Such a low profit margin, a little careless, may make the company fall into a loss, fall to the bottom, and then fail to climb up at the bottom.

Pfizer suddenly found out, why the number of patent lawsuits has increased?

There are also cooperation negotiations with other pharmaceutical companies before. The talks were good, but suddenly the other party directly and unilaterally terminated the negotiations.

And some of the previous hospitals, clinics, pharmacies, etc. suddenly stopped ordering their Pfizer drugs.

Anyway, Pfizer's medicines are not irreplaceable, and the same is true for ordering other companies, otherwise those pharmaceutical companies will stop supplying them.

This clearly is to jointly suppress Pfizer!

If it was before, Pfizer could still turn around with some of its own special medicines, but now it can't. Pfizer finally felt scared this time.

Cun Bole saw that after Xinming Pharmaceutical announced the price of the new drug, all the pharmaceutical companies in the world were calling for Xinming Pharmaceutical, and he knew that Pfizer was really finished this time.

Ps: solve the flower, ask for evaluation, ask for automatic ordering! ! !Down

Chapter [-]: Pfizer goes bankrupt!

The next day, Pfizer's stock price plummeted.

Including those investment institutions that have previously analyzed that Pfizer can still be profitable and hold a large number of Pfizer stocks, all of them have also begun to ship.

, Weijue will smash his hands, and he can't sell it at a low price.

Who is slow

At this time, no one said to buy Pfizer's stock at the bottom, because it has never been able to see the bottom.

Pfizer's board of directors, Aberdeen stands up and bows to all shareholders

"I'm sorry, my aggressive strategy this time, I wanted Xinming Pharmaceutical to reduce the price of their special cancer drugs and reduce their profits, but I didn't want to.

Until they lowered the price of commonly used drugs such as antihypertensive drugs.

"Our drug profit margins at Pfizer will fall sharply, sales will fall sharply, and the fourth-quarter report will be ugly.

"I said before that if this strategy led to Pfizer's '[-]' losses, I would take the blame and resign. Now is the time to elect a new chairman who will lead the

Pfizer is reborn.

After Aberle finished speaking, he wanted to leave, but was stopped by the shareholders.

"Eberle, if you apologize and resign, it's over?

"Then what about our losses? You are fully responsible!"

One person is [-]%, [-]%, etc. More than [-]% of investors are few.

The shareholding ratio of those shareholders may not be too high,

- Some people have more voting rights.

This is the case with many large corporate investments.

But Pfizer's previous market value is there, and there are more than [-] billion US dollars. The Pfizer shares held by these shareholders are worth billions of dollars, and the

It is the most important asset of many people.

The stock price of orphans fell sharply,

Each of them lost more than a third of their net worth!

Pfizer's market value has also fallen below [-] billion US dollars, and once this happens, some of Pfizer's previous loans will also be called by banks.

This is the case with stock mortgage loans. At any time, the stock price may fall, causing the bank to collect debts on the grounds that the risk is too high and the value of the collateral is insufficient.

Ai Bo Le asked back: "I used to work for the company, how about the money I made for you?

"Without me, Pfizer wouldn't have been the No. [-] global pharmaceutical company for so many years!

A quarrel soon broke out on the board of directors, and Abel slapped the table with some shareholders and shouted at each other.

Eberle will not compensate, he is so old that he can enjoy retirement.

It is also a drop in the bucket for his assets to be paid to shareholders. At this time,

You have to think about yourself.

Pfizer's affairs will suddenly become leaderless, and the company's operations will also have problems.

Coupled with so many lawsuits, so many peers' joint suppression, and bank debt collection, after these were exposed, Pfizer's stock price fell even more.

When Fu Liang heard the news, he was also surprised.

'Aberle resigned, and Pfizer has no leader? How could such a big company become like this, and who took over as the president?

Xiao Wang said with a smile: "It's Williams, who has been struggling with how to stabilize the stock price and how to stop the bank from collecting debts.

"It's mainly because major pharmaceutical companies joined forces to block Pfizer's drug sales channels. Pfizer's own patented drug sales continued to decline.

Litigation lawsuit, Pfizer has lost the trust of shareholders and banks.

"I heard that Pfizer intends to recruit me, but I also need to pay a large amount of compensation. Pfizer can't get this money now.

Pfizer used to be the world's No. [-] pharmaceutical company, and its profit margin was in the top ten or even the top five among the top [-] companies all year round.

More than Google, Facebook and other technology companies, the limelight is no different

At that time, it was a leader, if not the absolute hegemon of global pharmaceutical companies.

But in just over a year, Pfizer has experienced a sharp decline in its share price, corporate transformation, and even now its market value has been cut in half.

The major pharmaceutical companies joined forces to target Pfizer, which also surprised Fu Liang.

"Boss, I inquired from Johnson & Johnson, because major pharmaceutical companies are worried that our medicines will continue to cut prices, and even other medicines will be sold at low prices in the future.

"In this way, we still have profits, but the profits of other pharmaceutical companies will fall sharply.

They believe that the reason for all this is the accusations of Pfizer, which broke the tacit understanding between pharmaceutical companies, so they are so targeted at Pfizer.

, after all, the competition between peers has never been less.

"It may also be that when Pfizer was the leader, it made too many enemies.

"When some companies see an opportunity, of course they want to take a bite or step on it.

'Johnson & Johnson also hinted that we hope our new drug prices will not continue to fall, otherwise it will affect the entire industry.

Fu Liang shrugged, and he didn't want to affect the entire industry.

However, it is inevitable for pharmaceutical companies to reshuffle the market and divide the market.

Fu Liang will occupy [-]% of the market for cancer drugs in the future, which is enough to ensure that he has tens of billions of dollars in net profit every year.

In addition to the medicines such as Shengfaling, Sutongbu, height-increasing drugs, and fat-burning drugs, who can make more money than him?

At that time, even the top [-] giants like Wal-Mart will not dare to compare profits with Fu Liang.

Any industry goes through wild times from the beginning.

, to the group of heroes, then divided into strata, and finally stabilized

The existing global pharmaceutical market is an era of divisions, and Pfizer was once in a leading position.

Until Fu Liang appeared, breaking the balance, the leader would soon be replaced.

In the future, no pharmaceutical company can challenge Fu Liang, and Fu Liang's laboratory will lead the way!

"Okay, tell Johnson & Johnson, no one provokes me, and I don't want to lower the price, after all, it also reduces my income

"But I don't think people hit Pfizer hard enough.

Through Johnson & Johnson, Fu Liang's words reached the ears of shareholders of other pharmaceutical companies, and they all knew what to do.

Isn't it just to kill Pfizer, which is what they want to do.

If Pfizer's assets can be divided up, they can also grow a little bit.

, and found some places to criticize Pfizer.

Qian is the world's top pharmaceutical company once again making efforts in 3.2,

Xingrui's market value finally fell below $[-] billion, and Pfizer's profit this month also turned negative for the first time.

When Pfizer started to lose money, the golden body was completely broken.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like